238 related articles for article (PubMed ID: 4005802)
1. The value of morphometry to classic prognosticators in breast cancer.
Baak JP; Van Dop H; Kurver PH; Hermans J
Cancer; 1985 Jul; 56(2):374-82. PubMed ID: 4005802
[TBL] [Abstract][Full Text] [Related]
2. Nuclear morphometry and mitotic indexes as prognostic factors in breast cancer.
Aaltomaa S; Lipponen P; Eskelinen M; Alhava E; Syrjänen K
Eur J Surg; 1991 May; 157(5):319-24. PubMed ID: 1678644
[TBL] [Abstract][Full Text] [Related]
3. Comparison of classic and quantitative prognostic factors in hormone receptor-positive and hormone receptor-negative female breast cancer.
Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
Am J Surg; 1993 Mar; 165(3):307-11. PubMed ID: 8447534
[TBL] [Abstract][Full Text] [Related]
4. Mitotic indexes as prognostic predictors in female breast cancer.
Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
J Cancer Res Clin Oncol; 1992; 118(1):75-81. PubMed ID: 1729263
[TBL] [Abstract][Full Text] [Related]
5. Tumor size, nuclear morphometry, mitotic indices as prognostic factors in axillary-lymph-node-positive breast cancer.
Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
Eur Surg Res; 1992; 24(3):160-8. PubMed ID: 1499604
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of morphometry and DNA flow-cytometry features of invasive breast cancers detected by population screening: comparison with control group of hospital patients.
Uyterlinde AM; Baak JP; Schipper NW; Peterse HJ; Meijer JW; Vooys PG; Matze E
Int J Cancer; 1991 May; 48(2):173-81. PubMed ID: 2019464
[TBL] [Abstract][Full Text] [Related]
7. Morphometric grading in breast cancer: thresholds for mitotic counts.
Kronqvist P; Kuopio T; Collan Y
Hum Pathol; 1998 Dec; 29(12):1462-8. PubMed ID: 9865834
[TBL] [Abstract][Full Text] [Related]
8. Morphometry and breast cancer. II. Characterisation of breast cancer cells with high malignant potential in patients with spread to lymph nodes: preliminary results.
van der Linden HC; Baak JP; Lindeman J; Hermans J; Meyer CJ
J Clin Pathol; 1986 Jun; 39(6):603-9. PubMed ID: 3722413
[TBL] [Abstract][Full Text] [Related]
9. Prognostic indicators in breast cancer--morphometric methods.
Baak JP; Kurver PH; De Snoo-Niewlaat AJ; De Graef S; Makkink B; Boon ME
Histopathology; 1982 May; 6(3):327-39. PubMed ID: 7095760
[TBL] [Abstract][Full Text] [Related]
10. The significance of nuclear morphometric variables as prognostic predictors in breast cancer.
Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
Anticancer Res; 1991; 11(4):1663-9. PubMed ID: 1746922
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of proliferative activity in lymph node metastases of patients with breast cancer.
van Diest PJ; Matze-Cok E; Baak JP
J Clin Pathol; 1991 May; 44(5):416-8. PubMed ID: 2045501
[TBL] [Abstract][Full Text] [Related]
12. Quantitative histopathology in ductal carcinoma of the breast. Prognostic value of mean nuclear size and mitotic counts.
Ladekarl M
Cancer; 1995 Apr; 75(8):2114-22. PubMed ID: 7697602
[TBL] [Abstract][Full Text] [Related]
13. Computer-generated nuclear features compared with axillary lymph node status and tumor size as indicators of breast cancer survival.
Wolberg WH; Street WN
Hum Pathol; 2002 Nov; 33(11):1086-91. PubMed ID: 12454812
[TBL] [Abstract][Full Text] [Related]
14. Prognostic scores combining clinical, histological and morphometric variables in assessment of the disease outcome in female breast cancer.
Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
Int J Cancer; 1991 Dec; 49(6):886-92. PubMed ID: 1959993
[TBL] [Abstract][Full Text] [Related]
15. The morphometric prognostic index is the strongest prognosticator in premenopausal lymph node-negative and lymph node-positive breast cancer patients.
van Diest PJ; Baak JP
Hum Pathol; 1991 Apr; 22(4):326-30. PubMed ID: 2050366
[TBL] [Abstract][Full Text] [Related]
16. The impact of mitotic index on predicting outcome in breast carcinoma: a comparison of different counting methods in patients with different lymph node status.
Laroye GJ; Minkin S
Mod Pathol; 1991 Jul; 4(4):456-60. PubMed ID: 1924277
[TBL] [Abstract][Full Text] [Related]
17. [Lobular invasive breast cancer prognostic factors: About 940 patients].
Jauffret C; Houvenaeghel G; Classe JM; Garbay JR; Giard S; Charitansky H; Cohen M; Bélichard C; Faure C; Darai É; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Coutant C; Dravet F; Chauvet MP; Chéreau Ewald E; Penault-Llorca F; Goncalves A; Lambaudie É
Gynecol Obstet Fertil; 2015 Nov; 43(11):712-7. PubMed ID: 26482833
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the prognostic value of four methods to assess mitotic activity in 186 invasive breast cancer patients: classical and random mitotic activity assessments with correction for volume percentage of epithelium.
Jannink I; van Diest PJ; Baak JP
Hum Pathol; 1995 Oct; 26(10):1086-92. PubMed ID: 7557941
[TBL] [Abstract][Full Text] [Related]
19. Quantitative histopathology in lymph node-negative breast cancer. Prognostic significance of mitotic counts.
Ladekarl M; Jensen V
Virchows Arch; 1995; 427(3):265-70. PubMed ID: 7496595
[TBL] [Abstract][Full Text] [Related]
20. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
Diel IJ; Kaufmann M; Costa SD; Holle R; von Minckwitz G; Solomayer EF; Kaul S; Bastert G
J Natl Cancer Inst; 1996 Nov; 88(22):1652-8. PubMed ID: 8931609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
